Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Genomics signatures in uterine cancers could offer clues to prognosis. The first comprehensive genomic analysis of endometrial tumors divides the cancer into four subtypes and suggests potential changes to current treatment paradigms. The study, published on Wednesday in the scientific journal Nature, is the latest result of the Cancer Genome Atlas, a U.S.-funded effort to improve cancer treatment with better diagnoses and targeted drug treatments.
Hey, check out all the research scientist jobs. Post your resume today!
